Smoking cessation treatment and risk of depression suicide and self harm

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=mVncR4eXcFk

Read the full open access research: http://www.bmj.com/content/347/bmj.f5704 • Smoking is a major cause of premature mortality and preventable morbidity in the United Kingdom and worldwide.Treatments such as varenicline, bupropion, and nicotine replacement therapy, along with advice and referral to smoking cessation services, are recommended by the National Institute for Health and Care Excellence as options for smokers who want to quit smoking. • Since their launch, there have been concerns from spontaneous reporting systems that varenicline and bupropion could increase the risk of fatal and non-fatal self harm; these have resulted in safety warnings by regulatory agencies, including the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK and the Food and Drug Administration in the United States. • In this study the authors set out to compare the risk of suicide, self harm, and depression in patients prescribed varenicline or bupropion with those prescribed nicotine replacement therapy using a prospective cohort in the UK.

#############################

New on site